共 50 条
- [33] THE ACCURACY OF DRUG INFORMATION FROM PHARMACEUTICAL SALES REPRESENTATIVES [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (16): : 1296 - 1298
- [35] Physicians, pharmaceutical representatives, and patients: Who really benefits? [J]. JOURNAL OF FAMILY PRACTICE, 2000, 49 (09): : 817 - 819
- [37] General practitioners and pharmaceutical sales representatives: Quality improvement research [J]. QUALITY & SAFETY IN HEALTH CARE, 2007, 16 (04): : 266 - 270
- [38] INVOLVEMENT OF PHARMACY FACULTY IN THE DEVELOPMENT OF POLICIES FOR PHARMACEUTICAL SALES REPRESENTATIVES [J]. JOURNAL OF FAMILY PRACTICE, 1992, 34 (01): : 49 - 52
- [39] PHYSICIAN CONTACTS WITH PHARMACEUTICAL SALES REPRESENTATIVES IN MEDICINE TEACHING PROGRAMS [J]. CLINICAL RESEARCH, 1988, 36 (03): : A349 - A349
- [40] NATIONAL SURVEY OF HOSPITAL POLICIES ON PHARMACEUTICAL SALES REPRESENTATIVES ACTIVITIES [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (06): : 1334 - 1340